Anest. intenziv. Med. 2010;21(3):134-139

Xenon inhalational anaesthesia in volunteersAnaesthesiology - Original Paper

Török Pavol1,*, Hermely Albert1, Sopko Imrich1, Čandík Peter1, Saladiak Stanislav1, Sýkora René1, Májek Milan2
1 OAIM VÚSCH, a. s., Košice
2 KAIM SZU, FNsP - Dérerova nemocnica, Bratislava

Objective:
We describe the first experimental administration of xenon inhalational anaesthesia in volunteers. The primary aim was administering a short inhalational xenon anaesthesia and learning the technique and technology of its administration. The secondary aim was observing objective physiological and laboratory parameters and the subjective feelings of the subjects who had undergone the anaesthesia.
Setting:
Department of Anaesthesia and Intensive Medicine.

Design:
Clinical experiment (Approval No. 21082009 of the Ethical Committee).

Materials and methods:
The objective effects of xenon anaesthesia on the physiological variables and laboratory tests and its subjective perception until the loss of consciousness by the subjects were tested in a group of 5 volunteers. Two subjects reached the first two depth levels of anaesthesia and the remaining subjects reached levels 3 and 4 of xenon anaesthesia. All the subjects were monitored and managed in a standard fashion.

Results:
The laboratory tests were performed prior to and 15 minutes after the anaesthesia. There were no significant differences found in the results before and after the anaesthesia. No result exceeded the normal range. Blood pressure and heart rate were stable, without significant changes, during the course of anaesthesia. Ventilatory parameters showed minor changes, the heart rate decreased and breathing became temporarily deeper but after reaching anaesthesia depth-levels 3 and 4, all the parameters became normal again. SpO2 was stable, oscillating between 97 and 100%, ETCO2 reached 4.6-5.2 kPa. The authors evaluated the subjective perception by the anaesthetized persons at the moments when xenon concentration in the airways reached a relatively stable concentration at 10, 20, 30, 40 and 50%.

Conclusion:
This experiment is one of the first ones in the field of gaining technical skills and experience in performing xenon anaesthesia. For the volunteers, all of whom are anaesthetists, this was a unique personal experience. The authors expect early implementation of xenon anaesthesia into their clinical anaesthetic practice in indicated cases.

Keywords: xenon; inhalational anaesthesia

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Török P, Hermely A, Sopko I, Čandík P, Saladiak S, Sýkora R, Májek M. Xenon inhalational anaesthesia in volunteers. Anest. intenziv. Med. 2010;21(3):134-139.
Download citation

References

  1. Virtue, R.V. Minimal flow N2O anaesthesia. Anaesthesiology, 1974, 40, p. 196-198. Go to original source... Go to PubMed...
  2. Larsen et al. Anestezie. Grada publishing: Praha, 2004, p. 903.
  3. Török, P. Monitorovanie počas anestézie a na OAIM. In: Firment et al. Základy anesteziológie. LF UPJŠ: Košice, 2001, p. 302.
  4. Török, P. Inhalačná anestézia - súčasný stav. Možné a potrebné technické riešenia v SR s výhľadom integrácie do EÚ. Materiál výboru SSAIM pre MZ SR, 2000, s. 4.
  5. Bamert, J. H., Falter, F., Eletr, D. et al. Xenon anaesthesia may preserve cardiovascular function in patients with heart failure. Acta Anaesthesiol. Scand., 2005, 49, p. 743-749. Go to original source... Go to PubMed...
  6. Baumert, J. H., Hecker, K. E., Hein, M. et al. Effects of xenon anaesthesia on the circulatory response to hypoventilation. British Journal of Anaesthesia, 2005, 1, p. 166-171. Go to original source... Go to PubMed...
  7. Baumert, J. H., Hein, M., Hecker, K. E. et al. Autonomic cardiac control with xenon anaesthesia in patients at cardiovascular risk. British Journal of Anaesthesia, 2007, 5, p. 722-727. Go to original source... Go to PubMed...
  8. Bedi, A., McBride, W. T., Armstrong, M. A. et al. Xenon has no effect on cytokine balance and adhesion molecule expression within an isolated cardiopulmonary bypass system. British Journal of Anaesthesia, 2002, 3, p. 546-550. Go to original source... Go to PubMed...
  9. Burov, N. E, Korienko, L. JU., Džabarov, D. A., Mironova, I. I. Gemodinamika i funkcia myokarda pri xenonnoj anestezii. Anesteziologia i Reanoimatologia, 1993, 5, p. 57-59.
  10. Burov, N. E, Korienko, L. JU., Džabarov, D. A., Mironova, I. I. Vlijanie anestezii ksenonom na morfologiu i svertyvajuščuju systemu krovi. Anesteziologia i Reanoimatologia, 1993, 6, p. 14-18.
  11. Burov, N. E., Korienko, L. JU., Makaev, G. N., Potapov, V. N. Kliničesko experimentaľnoe issledovania anestezii xenonom. Anesteziologia i Reanoimatologia, 1999, 6, p. 56-60.
  12. Burov, N. E., Korienko, L. JU., Makaev, G. N., Potapov, V. N. Alternatvnoe sposoby udeševljeni anetezii xeonom. Anesteziologia i Reanoimatologia, 1997, 4, p. 71-73.
  13. Burov, N. E., Korienko, L. JU., Makaev, G. N., Potapov, V. N. Anesezia xenonom, sostojanie i perspektivy primenenia v chirurgii. Annaly chirurgii, 1998, 4, p. 60-64.
  14. Burov, N. E., Potapov, V. N. Xenon v prektičeskoj anesteziologii, Sostojanie i perspektivy primenenija v Rosii. V zborníku: Xenon i xenonsberajuščie technologii v medicine - 2005. Moskva, 2005. p. 57-62.
  15. Kozlov, I. A., Voronin, S. V. Xenon pri operaciach na serdce-kačestvcenno novyj variant obščej anestezii. Zdravoochranenie i medicinska technika, 2004, 10, p. 10-12.
  16. Kozlov, I. A. Izofluran a Xenon v anesteziologii. Vestnik intensivnoj terapii, 2003, 3, p. 23-29.
  17. Kozlov, I. A., Chubutia, A. S., Voronin, S. V. Pervyj opyt s anesteziej xenonom pri operacijach s iskustvennym krovoobraščeniem. Serdečno sosudnyje zabolevanija, 2003, 6, p. 125.
  18. Goto, T., Nakata, Y., Morita, S. Will xenon be a stranger or a friend? The cost, benefit, and future of xenon anesthesia. Anesthesiology, 2003, 98, p. 1-2. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.